-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Avenue Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2016 to Q2 2025.
- Avenue Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $175K, a 8.85% decline year-over-year.
- Avenue Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $1.21M, a 3.04% decline year-over-year.
- Avenue Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1.24M, a 36.4% increase from 2023.
- Avenue Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $906K, a 39.6% increase from 2022.
- Avenue Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $649K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)